NASDAQ
Lattice Biologics Ltd. (LBLTF) has a free cash flow growth of 100.39% as of Friday, May 29, 2026. This represents a 129.17% increase compared to its 12-month average of -344.20%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.